Organovo Holdings, Inc. (ONVO)
-NYSE MKT | Prev Close: | 5.83 |
|---|
| Open: | N/A |
|---|
| Bid: | 5.66 x 1000 |
|---|
| Ask: | 6.40 x 200 |
|---|
| 1y Target Est: | N/A |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | N/A - N/A |
|---|
| 52wk Range: | 1.80 - 8.50 |
|---|
| Volume: | 0 |
|---|
| Avg Vol (3m): | 2,990,050 |
|---|
| Market Cap: | 446.04M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Other EventsEDGAR Online(Tue, Oct 1)
- 4 Stocks Under $10 Making Big Movesat TheStreet(Wed, Sep 25)
- 5 of Last Week's Biggest Winnersat Motley Fool(Sun, Sep 22)
- 3 Critical Details for This 3-D Printing Stockat Motley Fool(Fri, Sep 20)
- 5 Biotech Stocks Under $10 on the Moveat TheStreet(Fri, Sep 20)
- What JP Morgan Thinks About the 3-D Printing Industryat Motley Fool(Thu, Sep 19)
- ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Other EventsEDGAR Online(Thu, Sep 19)
- Harvard Bioscience Bulls Need A Lot Of HARTat Seeking Alpha(Tue, Sep 17)
- Organovo May Be Big Pharma's Salvationat Seeking Alpha(Tue, Sep 17)
- Organovo, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.comPR Newswire(Mon, Sep 16)
- Organovo's Focus On Long-Term Value Creation Going Unnoticedat Seeking Alpha(Thu, Sep 12)
- Neonode: Investors Feel Duped, Shares To Fall Furtherat Seeking Alpha(Wed, Sep 11)
- ORGANOVO HOLDINGS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Wed, Sep 11)
- NexGen Life Sciences Virtual Investor Conference Brings Companies, Analysts and Investors Together on September 12thCNW Group(Tue, Sep 10)
- NexGen Life Sciences Virtual Investor Conference Brings Companies, Analysts and Investors Together on September 12thPR Newswire(Tue, Sep 10)
Comparison
| Symbol | % Chg | Mkt Cap |
|---|
| ONVO | 0.00% | 446.04M |
| TMO | 0.00% | 33.47B |
| A | 0.00% | 17.17B |
| WYETH.BO |  0.03% | 13.14B |
| WYETH.NS | 0.71% | 13.08B |
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 391.60 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Organovo Holdings, Inc. develops three-dimensional (3D) bioprinting technology for creating functional human tissues on demand for research and medical applications.
View More